Women facing hormonal imbalances from menopause, PCOS (Polycystic Ovary Syndrome), or endometriosis often find themselves struggling with stubborn weight gain, fatigue, insulin resistance, and increased inflammation. Traditional diets and exercise sometimes aren't enough—and that’s where GLP-1 medications like semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™) come into play. Originally designed for diabetes management, these medications are now showing powerful benefits for women managing hormone-related conditions.

Microdosing on a GLP-1 medication means starting with a lower dose and gradually increasing over time to allow your body to adjust more gently. This approach can minimize common side effects like nausea while still helping to control appetite and support steady, sustainable weight loss. It’s also a great option for maintaining your results long-term—many clients continue on a low dose after reaching their goal weight to help prevent rebound weight gain and stay on track.